Business Wire

Cofactor Genomics expands clinical use of OncoPrism, as their AI enabled RNA test achieves national clinical validation after predicting immunotherapy response in Lung Cancer ...

ST. LOUIS--(BUSINESS WIRE)--Cofactor Genomics, Inc., a clinical-stage company bridging the precision medicine gap by decoding RNA, announced today the validation and launch of OncoPrism ®-NSCLC, an ...
Yahoo Finance

Cofactor Genomics Publishes Clinical Validation of OncoPrism-HNSCC, a Test Leveraging Novel RNA Modeling Technology to Predict Response to Immunotherapy

ST. LOUIS, November 07, 2024--(BUSINESS WIRE)--Cofactor Genomics, Inc., a clinical-stage company bridging the precision medicine gap by decoding RNA, announced the publication of their PREDAPT ...
iaea.org

Developing a phenomena identification and ranking table (PIRT) and a validation matrix, and performing a benchmark for In-Vessel Melt Retention

Belgium, Bulgaria, Canada, China, Czech Republic, Germany, Finland, France, United Kingdom of Great Britain and Northern Ireland, Republic of Korea, Lithuania ...